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Differentiation of Crystals Associated With Arthropathies by
Spectral Photon-Counting Radiography
A Proof-of-Concept Study
Florian Alexander Huber, MD,* Fabio Becce, MD,† Spyridon Gkoumas, PhD,‡ Thomas Thüring, PhD,‡
Sylvain Steinmetz, MD,§ Igor Letovanec, MD,|| and Roman Guggenberger, MD*
Objectives: The aims of this study were to test whether spectral photon-counting
radiography (SPCR) is able to identify and distinguish different crystals associ-
ated with arthropathies in vitro and to validate findings in a gouty human third
toe ex vivo.
Materials and Methods: Industry-standard calibration rods of calcium pyro-
phosphate, calcium hydroxyapatite (HA), and monosodium urate (MSU) were
scanned with SPCR in an experimental setup. Each material was available at 3
different concentrations, and a dedicated photon-counting detector was used for
SPCR, whereas validation scans were obtained on a clinical dual-energy com-
puted tomography (DECT) scanner. Regions of interest were placed on SPCR
images and consecutive DECT images to measure x-ray attenuation characteris-
tics, including effective atomic numbers (Zeff). Statistical tests were performed
for differentiation of Zeff between concentrations, materials, and imaging modal-
ities. In addition, a third toe from a patient with chronic gouty arthritis was scanned
with SPCR and DECT for differentiation of MSU from HA.
Results: In both SPCR and DECT, significant differences in attenuation and Zeff
values were found for different concentrations among (P < 0.001) and between
different materials (P < 0.001). Overall, quantitative measurements of Zeff did
not differ significantly between SPCR- and DECT-derived measurements
(P = 0.054–0.412). In the human cadaver toe, gouty bone erosions were visible
on standard grayscale radiographic images; however, spectral image decomposi-
tion revealed the nature and extent of MSU deposits and was able to separate it
from bone HA by Zeff.
Conclusions: Identification and differentiation of different crystals related to ar-
thropathies are possible with SPCR at comparable diagnostic accuracy to DECT.
Further research is needed to assess diagnostic accuracy and clinical usability in vivo.
Key Words: crystal arthropathies, gout, monosodium urate, radiography, spectral
photon-counting radiography
(Invest Radiol 2020;00: 00–00)
I dentification of chemical compounds among the broad spectrum ofcrystal-associated arthropathies is known to be crucial for successful
long-term therapy.1–3 Gout, as the most frequent crystal-associated dis-
ease with typical subcutaneous and juxta-articular tophi, is primarily
diagnosed by polarized light microscopy where monosodium urate
(MSU) crystals in aspirated synovial fluid or biopsied tissue4,5 can be
identified with high specificity. However, in cases with negative
microscopy results but high clinical suspicion, further investigation
by ultrasound imaging and in particular dual-energy computed to-
mography (DECT) is now recommended by the European League
Against Rheumatism.4
Provided with a certain density threshold, DECT is known to reli-
ably discriminate MSU-containing tophi from calcium-containing crys-
tals such as calcium pyrophosphate (CPP) or calcium hydroxyapatite
(HA).4,6–10 Furthermore, utilization of spectral photon-counting (PC)
detectors in CT has recently been proven to enable discrimination be-
tween different crystal suspensions evenmore accurately.11,12 The basic
principle behind PC techniques is the use of novel detectors that are ca-
pable of discriminating different x-ray photon energies. As materials
interact differently with x-ray radiation, the energy levels of resulting
photons vary depending on the atomic structure of the scanned object.
Therefore, this principle has intensely been investigated over the past
decades in material science.13,14 However, CT-based examinations are
associated with substantial radiation burden, which hampers suitability
of CT for opportunistic screening or disease monitoring in vivo.15 To
improve this limitation in applicability, a variety of strategies are currently
being discussed, most importantly the utilization of PC and machine
learning in image reconstruction, which have already shown promising
results regarding the reduction of dose without compromise on image
quality.16–18
Plain radiography on the other hand is a comparably cheap mo-
dality with broad access and uses markedly less ionizing radiation com-
pared with CT for both the body trunk as well as for the appendicular
skeleton.19,20 However, compared with DECT, it has a much lower di-
agnostic performance in detection of gouty tophi because of in-plane
superposition of tissues and without the possibility of material decom-
position based on attenuation at different energy levels.4,21 This has grad-
ually led to a decline of conventional radiography in the diagnosis of
gout4 and a controversially discussed role in CPP deposition disease.22
Nonetheless, after decades of constantly increasing the use of
cross-sectional imaging, recent technologic innovations have sparked
new interest in conventional radiography. Exemplarily,De Silvestro et al23
have shown an added value of tomosynthesis in the field of musculoskel-
etal radiology, proving significantly better assessment of fracture healing
in the hand andwrist, when compared with standard digital x-rays. More-
over, the benefits of bone removal, lung nodule detection, and others in
dual-energy chest radiography have been proven useful.24–26 A recent
in vitro investigation of spectral photon-counting radiography (SPCR)27
has shown promising results in the identification of crystals related
to arthropathy, reviving interest in plain radiography for this diagnosis
and its monitoring. Furthermore, dark-field radiography is also cur-
rently being investigated with respect to its usability for MSU
detection.28
The purpose of this study was to test whether SPCR can distin-
guish and identify various crystal suspensions related to arthropathy
by using a vendor-specific calibrated phantom and clinical DECT data
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as reference standard. Crystal identification was then validated on an
excised human third left toe from a chronic gouty arthritis patient to
prove possible clinical application of SPCR in vivo.
MATERIALS AND METHODS
Samples
Phantom
Industry standard samples of synthetic MSU, CPP, and HA crystals
at 3 different concentrations mimicking in vivo conditionswere used for all
scans: 200, 400, and 600 mg/mL of MSU and 50, 100, and 150 mg/mL
of CPP and HA, respectively. According to in vivo findings and empir-
ical data from previous pilot studies, MSU at 200mg/mL is a borderline
concentration for positive gout detection in the default DECT postprocessing
workflow. The maximum MSU concentration was the highest achievable
value by the manufacturer for ensuring a homogeneous phantom. Calcium
pyrophosphate and HA are known to be of higher attenuation; hence,
their concentrations were adapted accordingly. The respective concen-
trations were considered as “low,” “medium,” and “high.” All samples
were available as same-sized calibration rods at a diameter of 5 mm
each and homogeneous crystal concentrations (Fig. 1). The samples
were obtained from a CE-certified and Food and Drug Administration–
certified vendor for medical imaging phantoms (Computerized Imaging
Reference Systems, Inc, Norfolk, VA).
Human Specimen
In addition, an ex vivo fresh (thawed at room temperature) ana-
tomic specimen of the third toe of the left foot was harvested from a
65-year-old male patient with known chronic gouty arthritis who had sur-
gical amputation of his limb performed as the ultimate therapeutic option.
The presence ofMSUwas then confirmed by polarized light microscopy,
and the specimen was subsequently scanned with SPCR in perpendicular
standard views and with DECTwith routine protocol for gout assessment
of the foot.Written consent of the patient to use the biological material for
scientific purposes was given before surgery. Institutional review board
approval was waived, as data inclusion concerned less than 5 patients,
in compliance with local and national ethics regulations.
SPCR Image Acquisition, Calibration, and
Postprocessing
All samples were scanned using a microfocus source x-ray tube
(Hamamatsu microfocus x-ray source L9181-02; Hamamatsu Photonics
K.K., Hamamatsu, Shizuoka Prefecture, Japan), a standard 0.52-mm alu-
minum filter, and an industry-standard high-resolution PC detector proto-
type of the latest generation (blinded). Tube-detector distance and tube
voltage were chosen similar to presets of a clinical standard radiograph
and kept constant throughout all scans. The respective acquisition and
image reconstruction parameters are listed in detail in Table 1. Because
of the complexity of dose calculations under clinical conditions, we de-
cided to estimate dose ranges only using a standard simulation tool,29,30
instead of a systematic assessment. Based on a previous pilot study,27
quantitative results of our SPCR setup did not differ significantly
between low and high dose, given a range between 0.18 and 18 mAs
(ie, 300 μA tube current over an exposure time of 60 seconds). For the
parameters as stated in Table 1, the simulation output was an air kerma
of 191 μGy/mAs. For our different exposure values, this value was
multiplicated with the mAs, resulting in a dose estimate of 34.4 μGy
up to 3.44 mGy. As the conversion to organ dose (Sievert) is difficult
due to lack of organ-specific weighting factors at the appendicular skel-
eton, we compared our results with the clinical routine of 2 perpendic-
ular radiographic projections of the hand. These examinations usually
range approximately 1 to 5 mAs and were therefore considered compa-
rable with regard to radiation dose of the SPCR setup used in this study.
Calibration was necessary before material decomposition and
was performed with industry-standard pure plates in different
FIGURE 1. A–D, Cylindrical samples of monosodium urate (MSU), calcium pyrophosphate (CPP), and calcium hydroxyapatite (HA) in low, medium, and
high concentration (as explained in themanuscript), examined by (A and B) spectral photon-counting radiography, from left to right, respectively. The
samples are visualized in (A) a grayscale-coded absolute attenuation image and (B) a color-coded decomposition image. For better presentation, the
images were postprocessed to fit in 1 line (from 2 separate scans with identical acquisition parameters). C and D, Images show the same cylindrical
samples in representative axial images of DECT validation scan, whereHA, CPP, andMSUare ordered clockwise, in decreasing concentration, respectively,
starting at the 1-o'clock position. The last sample is a resin rod without any further additives. Panel C is a standard grayscale image (soft tissue kernel,
mixed sources), whereas panel D was extracted from the vendor workflow for gout detection. Note that despite quite high concentration of MSU, CT is
able to detect “tophi” only in the highest concentrated MSU rod, because of material separation by attenuation thresholding (>150 HU, clinically
validated and vendor-recommended threshold).
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thicknesses of polyvinyl chloride (1–16 mm) and acrylic glass
(polymethyl methacrylate; 2–48 mm).
Reconstructions were generated for energy windows of 15 to 25,
25 to 30, 30 to 35, and 35 to 50 keV. Image postprocessing for decomposed
images and determination of Zeff values was performed using the
method described in the original research of Alvarez and Macovski31
and Lehmann et al.32
Validation DECT Scans
All samples were additionally scanned with a DECT scanner of
the latest generation (Siemens Force; Siemens Healthineers Inc, Erlangen,
Germany) using the clinical standard protocol for gout assessment of
peripheral joints (dual-source imaging with tube voltages at 80 kV
and tin [Sn]–filtered 150 kV). For further acquisition and image recon-
struction parameters, see Table 1.
Image postprocessing and measurements of Zeff values were per-
formed using the corresponding CE-certified vendor software for tophus
detection (syngo.via CT Dual-Energy Gout; Siemens Healthineers Inc,
Erlangen, Germany). Minimum thresholds for Zeff analysis were set at
the recommended clinical standard of 150 Hounsfield units (HUs).8,9
Quantitative Analysis
Narrow rectangular regions of interest (ROIs) at a defined size of
2 pixels width and 60 pixels length were placed over the middle aspect
of the rods in the SPCR images to reduce the effects of the cylinder's
thickness variation to extracted quantitative values. Round ROIs of
1 mm2 (21 pixels) were placed in the central portions of the crystal
rod cross-sectional area on 10 consecutive images in DECT-derived Zeff
maps series, respectively. Thereby, means and standard deviations of
Zeff values for among modalities, HU values, and dual-energy indices
(DEIs) on DECT, aswell as gray values (GVs) in SPCRweremeasured.
Gray values were determined for each sample defined by GV ¼ − log
I
I0=ð ), where I and I0 were the intensities in the x-ray images measured
with and without object, respectively.
Statistical Analysis
Analysis of variance and post hoc Bonferroni correction for mul-
tiple comparisons were used for the evaluation of differences in Zeff,
DEI, and HU/GV among materials and concentrations in SPCR (GV
only) and DECT measurements, respectively. Furthermore, analysis of
variance was also used to test for material inhomogeneities among dif-
ferent measurement regions in the DECT-derived images. Student t test-
ing was used to test for differences between SPCR and DECT. All scan
results were processed with Excel (Microsoft Excel for Office 365 Ver-
sion 1810; Microsoft Co, Redmond, WA), whereas SPSS was used for
statistical analysis (IBM SPSS version 25; IBM Co, Armonk, NY). A
P value below 0.05 was considered statistically significant.
RESULTS
Phantom
In SPCR, significant differences in GVand Zeff values were found
for different concentrations of each material (F = 760–11,320, P < 0.001
for all) and for different materials at matching concentrations
(F = 840–7220, P < 0.001), respectively. For all samples, no significant
differences were observed for Zeff values among different DECT images
in the central portions of the respective rods (P = 1).
In general, quantitativemeasurements in SPCRwere comparable
with findings on DECT images, where HU, DEI, and Zeff values were
also significantly different among all materials (F = 14.5–6187.6, all
P's < 0.001) and among their respective concentrations per material
(F = 56.4–50,697.2, all P's < 0.001), except when comparing HU values
among Sn150kV images of all high concentration samples (F = 0.183,
P = 0.834).
Comparing mean Zeff values of identical concentrations and ma-
terials, no significant differences were found between SPCR andDECT,
except for MSU in low concentration (P < 0.05) as well as CPP and HA
in high concentrations (P < 0.001 for both).
A detailed overviewof SPCR- and DECT-derivedmeasurements
of all crystal suspensions used and their respective concentrations is
given in Table 2.
Although larger overlaps of materials were seen regarding GV,
substantial differences between calcium-containing crystals (CPP and
HA) andMSUwere noted in the respective Zeff and DEI values. Eventual
differentiation by those discriminators was always possible for MSU
versus CPP/HA, as Zeff of the highest concentrations of MSU ranged
markedly below the lowest concentrations of calcium-containing phan-
toms. The observed trends of attenuation behavior and Zeff were compa-
rable with findings in DECT (Fig. 2).
Human Specimen
Visual analysis in SPCR of the anatomic specimen showed typ-
ical bone erosions in the gout-affected distal interphalangeal joint of the
third left toe in grayscale radiographic images, yet without clear depic-
tion of MSU gouty tophi. Image decomposition of SPCR with color
coding of highly attenuating (GV > 0.90) materials with a Zeff ranging
between 6 and 8 as green revealed presence and extent ofMSU deposits
mostly concordant with DECT. Because we chose a very high attenua-
tion cutoff in SCPR color-coded images, disease extent was considered
to be depicted with good specificity but reduced visual sensitivity com-
pared with the vendor default setup of DECT postprocessing. This is,
TABLE 1. Scan Acquisition and Image Reconstruction Parameters in SPCR and in DECT
Parameter SPCR DECT
mAs 18 205/137
kVp 50 80/Sn150
Distances, source detector/source object, cm 100/90 NA, centered halfway
Energy bins, keV 15–25, 30–50 NA
Slice thickness/increment, mm NA 1/1.5
Kernel NA Qr36
Field of view, mm 60  80 110
Pixel size, mm2 0.15  0.15 0.215  0.215
Dose 0.18–18 mAs (dose simulation, 34.4 μGy to 3.44 mGy) 9.47 mGy (CTDIvol)
SPCR, spectral photon-counting radiography; DECT, dual-energy computed tomography; NA, not available.
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however, a product of arbitrary color coding independent from true
quantitative calculations. Postimaging validation by gross pathology
and histology confirmed the distribution pattern of gout tophi, whereas
polarized light microscopy confirmed the presence of MSU (Fig. 3).
DISCUSSION
This proof-of-concept study shows that identification and dis-
crimination of different concentrations of arthropathy-related crystals
are feasible with SPCR at comparable diagnostic accuracy to DECT.
In this study, beyond the identification of 3 crystal materials and concen-
trations in a high-end industry phantom, subcutaneous and intraosseous
(ie, within a gouty bone erosion) MSU deposits in and around the distal
interphalangeal joint of an excised human third left toe could also be
identified for the first time with SPCR, as confirmed by gross pathology,
histology, and polarized light microscopy. To the best of our knowledge,
this is the first description of the use of PC detectors in radiography for
this clinical application in the scientific literature.
This finding is concordant with and supported by our recently
performed initial study that suggested the ability of crystal differentia-
tion with SPCR.27 However, this previous purely in vitro experiment in-
cluded only 2 materials (MSU and HA), and quantitative results were
based on own-built suspensionswith subsequent crystal suspension het-
erogeneity. Distinguishing between MSU and other crystal-associated
arthropathies can be effectively performed using DECT. This technique
is already well described and hence established clinically.4,5,33 Dual-energy
computed tomography is usually performed to exclude subcutaneous tophi
in patients with high disease pretest probability and/or negative micro-
scopic results from synovial fluid aspiration, and to assess crystal bur-
den in known chronic gouty arthritis patients.4,6 On the other hand,
the widespread availability and good reproducibility of ultrasound for
gout assessment,34 despite the relative lack of specificity, further limit
the spectrum of indications for DECT. Eventually, considering that
DECT scans of a single extremity region imply a dose increase by at
least a hundredfold compared with a standard biplanar radiography,35,36
the latter would be an interesting modality for screening—voluntary or
opportunistic—and disease monitoring of crystal-associated arthropa-
thies, providing adequate identification of crystal nature.
With this proof-of-concept study, we demonstrate the possible
identification and differentiation of crystals in SPCR beyond visual as-
sessment based on plain attenuation (GV) but with additional informa-
tion on crystal nature based on Zeff. Although larger overlaps of materials
were seen regarding GV, substantial differences between calcium-containing
crystals (CPP and HA) and MSU were noted in the respective Zeff values
and consequently with DEI in DECT, respectively. The latter reflects a
material specific index that puts into relation the attenuation behavior
at 2 different tube potentials, that is, HU values at 80 kVand Sn150kV.
In addition, Zeff values derived from SPCR were highly concor-
dant with reference standard DECT derived values, except for MSU in
low concentration (P < 0.005) as well as CPP and HA in high concen-
trations (P < 0.001 for both). At first, this finding suggests reduced ac-
curacy in the highest and lowest Zeff samples of crystal suspensions but
may be explained by 2 reasons: first, despite using state-of-the-art
methods and well-accepted algorithms for prior calibration, it is known
that consideration of areal densities (ie, density  thickness in grams
per centimeter square) plays an essential role in Zeff accuracy. Although
our calibration materials were acrylic glass (areal density, 0.24) and
polyvinyl chloride (0.14), areal density of different MSU and HA/
CPP concentrations ranged somewhere around 0.1 to 0.3 (low to high
concentration) and 0.025 to 0.075, respectively. This perfectly matches
with the reduced comparability of low concentratedMSU, which was of
slightly lower areal density than the calibration materials, but also partly
HA/CPP, which ranked comparably farer off the calibration range. It is
common practice to apply extrapolation from the calibration data for
measurements outside range; however, this is naturally associated withTA
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larger errors/biases. Second, despite high homogeneity of crystal rods
and ROI measurements with maximum precision for delineation and
thickness calibration in SPCR, ROI widths of only 2 pixels because
of cylindric rod dimensions may be prone to measurement bias as com-
pared with 3D image information from DECT.
The SPCR technique supplements high-resolution spatial infor-
mation from conventional radiographywithmaterial decomposition from
multienergy imaging. A Zeff-based material decomposition per se would
also technically be possible with DE radiography.37 Yet, several benefits
come along with the utilization of PC technique, compared with DE.
Photon-counting detector can ensure minimal dose to the patient while
producing sharper images because of direct conversion sensors. Fur-
thermore, different to most DE techniques, patient motion–related
image blurring is usually not an issue in SPCR. The use of more than
2 energy bins may in addition lead to better specificity in material dis-
crimination and allow for future settings of multicontrast agent exami-
nations.12,38,39 Some of these findings have already been investigated,
and our results in general concur with previous CT studies from Kirkbride
et al11 and Stamp et al,12 who have proved increased accuracy of material
discrimination using PC-CT instead of DECT. Also, for other reasons,
such as excellent spatial resolution because of a reduction in image
noise, PC detectors are increasingly being investigated for CT imaging,40
and they are widely recognized as key components for personalized
functional imaging in the near future.41 Furthermore, Stamp et al12 have
similarly demonstrated visible differences in the extent of MSU be-
tween DECT and spectral PC-CT, as was also clearly shown in our
FIGURE 3. Comparison of grayscale spectral photon-counting radiography (SPCR) images (A and D), Zeff color-coded SPCR images (B and E), as well as
volume-rendered 3D reconstructions of validating dual-energy CT scans (C and F) in panels A to C lateral and panels D to F dorso-palmar views of an ex
vivo third left toe (anatomic cadaver specimen) from a 65-year-old male patient with known history of chronic gouty arthritis. The images clearly show
disease-typical bony erosions (exemplary dotted lines in A and D). In comparison, color-coded images (B and E, C and F), photograph of pathologic
dissection (G), as well as exemplary histologic hematoxylin and eosin stain (H) reveal significantly larger disease extent. Panels B and E are overlaps of a
standard grayscale visualization and a color-coded mask, which labels all highly attenuating structures with effective atomic numbers within the range
of monosodium urate (MSU; ie, tophi; green; arrowheads). The periarticular opacities can be clearly identified as gout manifestations. Corresponding
green areas were seen in CT (arrowheads in C and F) and in photographs as yellow tophaceous tissue during dissection (G, asterisks), which left typical
“washed out” spots after staining (H, also asterisks). The criterion standard of (I) polarized light microscopy confirmed the extensive presence of MSU
crystals; in the right upper corner of the panel, a magnified area shows an exemplary singular crystal (white arrows). The difference in MSU extent
between SPCR and DECT is owed to currently missing thresholds for minimum attenuation cutoffs, as established by diagnostic accuracy studies. The
authors chose the DECT setting as recommended by the vendor, whereas the SPCR color setting was chosen arbitrarily, and it was considered tomatch
most optimally with the criterion standard of anatomic resection, that is, not overexaggerating disease extent.
FIGURE 2. Comparison of quantitative attenuation descriptors of monosodium urate (MSU), calcium pyrophosphate (CPP), and calcium hydroxyapatite
(HA), measured by dual-energy CT (DECT) and by spectral photon-counting radiography (SPCR). Panel A compares the Hounsfield units (HUs; Mixed
kV image of routine gout postprocessing workflow) with SPCR-derived gray values (GVs; defined as written in the methods section). For better visual
comparability, GVs weremultiplied by 500. In B, Zeff of bothmodalities are compared. Panel C compares dual-energy indices (DEIs) fromDECT scans of
all materials and concentrations. All DECT measurements were performed at 10 consecutive images and are presented with usual boxplots. The
SPCR-related measurements represent the mean value of the continuous total measurement area.
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investigation (Fig. 3). This may further highlight the clinical need
and importance of novel modalities for correct crystal identification and
quantification in gout and related conditions.
The limitations of this study are inherent to its experimental de-
sign. Although the used medical imaging phantom was of high quality
and crystal compounds were homogeneously fabricated, in vivo condi-
tions may be more heterogeneous with even mixed deposits, that is,
coexistingMSU and calcium crystals.42 However, simulated conditions
should rather reflect limits of reference range to extrapolate to real in
vivo conditions. Althoughwewere able to reliably differentiate compounds
in all phantom and human specimen scans and could visually identify
crystalline MSU regions from possible confounders, we did not inves-
tigate the impact of material overlay. Surrounding soft tissue is known
to have comparable Zeff to MSU and can suggest high attenuation on
superimposed views. This may also result in inferior sensitivity and
specificity of SPCR compared with cross-sectional imaging with DECT
or PC-CT. Further, at present, SPCR is dependent on quite expensive
high-end detectors that allow for identification of different photon ener-
gies. Moreover, the detector in use was a prototype built with a compa-
rably small field of view. To reach broad acceptance, clinical applicability
and costs of this technique using larger detectors and fast postprocessing
will be crucial. Ideally, solutions should be sought that allow to upgrade
preexisting conventional radiography units with SPCR detectors, thereby
introducing the additional benefit of material decomposition to conven-
tional radiography with minor efforts.
In conclusion, both in vitro and ex vivo identification and differ-
entiation of crystals related to arthropathies are possible with SPCR at
comparable diagnostic accuracy to DECT. Further research is needed
to assess diagnostic accuracy and clinical usability of this new tech-
nique in vivo in clinical routine.
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